Oncternal Therapeutics, Inc. (ONCT)
Dec 3, 2024 - ONCT trading suspended
0.5266
-0.1670 (-24.12%)
Inactive · Last trade price on Dec 2, 2024
ONCT's stock price has decreased by -92.3% in the past year and price targets may not have had time to catch up.
Oncternal Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$10.00
Upside
+1,798.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Northland Capital Markets | Northland Capital Markets | Buy → Hold Downgrades $2 | Buy → Hold | Downgrades | $2 | +279.79% | Sep 12, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +3,318.15% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +3,508.05% | Jul 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +3,508.05% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $19 | Strong Buy | Maintains | $28 → $19 | +3,508.05% | May 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +5,217.13% | Apr 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $30 | Strong Buy | Maintains | $2 → $30 | +5,596.92% | Jan 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2 | Strong Buy | Reiterates | $2 | +279.79% | Dec 27, 2023 |
| Brookline Capital | Brookline Capital | Hold → Strong Buy Upgrades $40 | Hold → Strong Buy | Upgrades | $40 | +7,495.90% | Dec 4, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $40 | Hold → Strong Buy | Upgrades | $40 | +7,495.90% | Sep 18, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $26 | Hold | Reiterates | $26 | +4,837.33% | Sep 7, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 6, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 4, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 4, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $80 → $26 | Buy | Maintains | $80 → $26 | +4,837.33% | Apr 4, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.